After topping the Street's expectations with its Q3 earnings, Cipla announced plans to launch two key drugs in FY26—the respiratory drug Advair and the oncology drug Abraxane. Umang Vohra ...

Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment. Cipla has launched an innovative combination of 3 HIV/AIDS ...

NEW DELHI: Indian Pharmaceutical company Cipla has offered to manufacture an antiviral drug for bird flu called Zanamivir (Relenza) that is currently being manufactured by Glaxo Smithkline.

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

These U.S. sales are usually driven by tumour drug Lanreotide, Cipla's second-biggest revenue generator. However, the company had warned in October that certain supply chain issues related to the ...

Cipla will receive the manufacturing know-how from Gilead Sciences to manufacture the drug at a commercial scale. The emergency use authorization (EUA) by the US FDA will facilitate broader use of ...